State Street (NYSE:STT) executives highlighted what they described as a strong finish to 2025 and outlined expectations for ...
Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback